tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

INBX Stock Latest News

Company AnnouncementsInhibrx Biosciences Reports Promising Trial Results for INBRX-109
10d ago
8K
INBX
Inhibrx announces preliminary ozekibart data, initiates new expansion cohort
PremiumThe Fly
Inhibrx announces preliminary ozekibart data, initiates new expansion cohort
10d ago
INBX
PremiumCompany Announcements
Inhibrx Biosciences Secures $150M Loan for Growth
18d ago
8K
INBX
Inhibrx prevails in trade secret case with I-Mab
PremiumThe Fly
Inhibrx prevails in trade secret case with I-Mab
3M ago
IMAB
INBX
Inhibrx management to meet virtually with Jefferies
PremiumThe Fly
Inhibrx management to meet virtually with Jefferies
4M ago
INBX
PremiumCompany AnnouncementsInhibrx Biosciences Reveals Updated Corporate Presentation
6M ago
8K
INBX
Inhibrx Inc (INBX) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Inhibrx Inc (INBX) Q2 Earnings Cheat Sheet
6M ago
INBX
Inhibrx initiated with a Market Perform at JMP Securities
Premium
The Fly
Inhibrx initiated with a Market Perform at JMP Securities
6M ago
INBX
PremiumCompany Announcements
Inhibrx Biosciences Shares Latest Corporate Presentation Update
8M ago
8K
INBX
Inhibrx files to sell 2.45M shares of common stock for holders
PremiumThe Fly
Inhibrx files to sell 2.45M shares of common stock for holders
8M ago
INBX
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
8M ago
MOR
MUB
Inhibrx’s Strategic Financial Moves and Corporate Restructuring
PremiumCompany Announcements
Inhibrx’s Strategic Financial Moves and Corporate Restructuring
8M ago
8K
INBX
Sanofi completes acquisition of Inhibrx
PremiumThe FlySanofi completes acquisition of Inhibrx
8M ago
SNY
INBX
Inhibrx stockholder approve sale to Sanofi
Premium
The Fly
Inhibrx stockholder approve sale to Sanofi
8M ago
SNY
INBX
INBX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INBX Upcoming Earnings Report: What to Expect?
9M ago
INBX
Inhibrx downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Inhibrx downgraded to Hold from Buy at Jefferies
11M ago
SNY
INBX
Inhibrx reports Q4 EPS ($1.73), consensus ($1.04)
PremiumThe Fly
Inhibrx reports Q4 EPS ($1.73), consensus ($1.04)
11M ago
INBX
Inhibrx Announces Execution of Merger Agreement
PremiumMarket News
Inhibrx Announces Execution of Merger Agreement
1y ago
8K
INBX
Inhibrx Announces Merger and Spin-Off Agreements with Aventis
PremiumMarket News
Inhibrx Announces Merger and Spin-Off Agreements with Aventis
1y ago
8K
INBX
Inhibrx downgraded to Market Perform from Outperform at LifeSci Capital
PremiumThe FlyInhibrx downgraded to Market Perform from Outperform at LifeSci Capital
1y ago
INBX
M&A News: Sanofi Expands into Rare Diseases with Inhibrx Deal
Premium
Global Markets
M&A News: Sanofi Expands into Rare Diseases with Inhibrx Deal
1y ago
INBX
Inhibrx to sell INBRX-101 to Sanofi in $2.2B transaction
Premium
The Fly
Inhibrx to sell INBRX-101 to Sanofi in $2.2B transaction
1y ago
SNY
INBX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >